FDA Delays Final OK for Type 2 Drug Empagliflozin
The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at
Read MoreThe FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at
Read MoreThe Food and Drug Administration has approved the entry of dapagliflozin, a drug for treating type 2 diabetes, into the
Read MoreThe fellow who writes one of the blogs I visit each morning often features links to articles about the wonders
Read MoreAccording to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with
Read MoreIf you Google “type 2 diabetes drugs,” one website lists the names of 92 drugs that medical professionals have prescribed
Read More